Guardian Bio Analysis: $0.5M Raised

What is Guardian Bio?

Guardian Bio specializes in dendritic cell therapy aimed at restoring anti-cancer immunity in late-stage solid tumor patients. Their unique approach involves generating true cDC1s from a patient's own stem cells, addressing a critical bottleneck in cancer treatment. This innovation enables effective stimulation of the immune response against multiple cancer targets simultaneously.

Product Features & Capabilities

• Proprietary process to generate cDC1s from patient stem cells
• Restoration of antigen presentation in late-stage cancer patients
• Stimulation of immune response against multiple cancer targets
• Activation of various effector immune cells
• Development of dendritic cell-based therapies for cancer and HIV.

How much Guardian Bio raised